Apple's Next Project: Tackling Heart Disease
Apple Inc. (NASDAQ: AAPL) is launching the Apple Heart Study, a program that will explore if using the Apple Watch to monitor heart rhythm can benefit patients, healthcare providers, and insurers. The study could save lives and drive demand for its products, so let's take a closer look.
Wearables represent a massive opportunity to improve patient health and, as a result, Apple's investing in hardware and software that can provide life-saving insight for people with an undiagnosed or chronic disease.
Image source: Getty Images.
Source: Fool.com
Apple Inc. Aktie
178,06 €
0,30 %
Mehr Buy- als Sell-Zahlen bei Apple Inc. zeigen ein leicht positives Sentiment.
Für Apple Inc. sieht die Community ein leicht positives Kursziel von 200 €, verglichen mit dem aktuellen Kurs von 178.06 €.
